Stocktoria
HYPERION DEFI, INC. HYPD
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2018-01-25
HYPERION DEFI, INC. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 62.7% | -6749.5% | -322.6% | — | 88.6% |
| Operating margin | -5743.5% | -85004.6% | -670885.8% | — | -93.0% |
| Net margin | -5570.6% | -86888.6% | -719859.9% | — | -91.3% |
| FCF margin | — | -52815.8% | -704624.5% | — | -157.9% |
| Return on assets | -87.5% | -1358.3% | -94.7% | -90.3% | -40.4% |
| Return on equity | -110.4% | 380.4% | -302.9% | -162.5% | -62.4% |
| Current ratio | 2.68 | 0.17 | 2.17 | 6.13 | 1.97 |
| Revenue growth | 1318.8% | 1414.0% | — | — | 600.0% |
Source: SEC EDGAR filings · CIK 0001682639 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.